Skip to content

Long-term nutritional outcomes after esophagectomy following induction chemotherapy versus chemoradiotherapy for T4b esophageal cancer

Sep 2026 · Esophagus · Vol 23, pp. 817 - 828 · 0 citations · 30 references
Medicine

TL;DR

Esophagectomy following induction chemoradiotherapy was associated with greater long-term weight loss and impaired nutritional recovery compared with surgery following chemotherapy alone, and these findings highlight the need for intensified nutritional surveillance and intervention in patients treated with preoperative CRT.

View source

Similar papers

Open access Sep 2026

Weight loss despite nutritional support predicts poor outcomes after postoperative chemoradiotherapy for high-risk head and neck cancer

Weight loss is common in patients with locally advanced head and neck squamous cell carcinoma (LA-HNSCC) and is associated with poor prognosis. However, its prognostic significance in patients receiving nutritional support from surgery through postoperative chemoradiotherapy (CRT) remains unclear. We evaluated the impa...

Yuka Inamochi, J. Yoshida, N. Fukuda et al. · 0 citations
Open access Aug 2026

P1.194. Timing of Esophagectomy After Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell Carcinoma

Esophagectomy performed beyond 8 weeks after neoadjuvant chemoradiotherapy is not associated with increased postoperative morbidity and may significantly reduce postoperative mortality without compromising pathological response, and delayed surgery appears safe and potentially advantageous.

C. Tandup, L. Singh, Manish Thakur et al. · 0 citations
Open access Aug 2026

P1.081. The Effect of Pre-Rehabilitation During Neoadjuvant Chemotherapy in Esophageal Cancer

Esophageal Cancer: Adjuvant and Neo-Adjuvant Therapies The standard treatment for resectable advanced esophageal squamous cell carcinoma is neoadjuvant chemotherapy (NAC) followed by surgery. Rehabilitation is recommended during NAC; however several adverse events often hinder its completion. This study ex...

Ryoma Haneda, E. Booka, Takahiro Kuroda et al. · 0 citations
Open access Aug 2026

Perioperative Nutritional Changes Predict Adjuvant S-1 Dose Intensity in Resectable Pancreatic Cancer

Background/Aim: Maintaining treatment intensity is important during adjuvant S-1 chemotherapy for resectable pancreatic cancer; however, factors associated with reduced relative dose intensity (RDI) during adjuvant chemotherapy (AC) remain unclear. This study investigated the association between perioperative inflammat...

Hiroo Suto, AN Fujita, Hibiki Sakai et al. · 0 citations
Sep 2026

Is postoperative adjuvant therapy necessary for esophageal cancer patients with pathological complete response after neoadjuvant treatment?

BACKGROUND Current National Comprehensive Cancer Network (NCCN) guidelines recommend omission of adjuvant therapy in esophageal cancer patients achieving pathological complete response (pCR) following neoadjuvant treatment. However, 20-40% of these patients experience disease recurrence, potentially indicative of resid...

Zi-An Zhang, Jun-Feng Liu, Jun-Hong Liu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.